Examining the Protective Role of ErbB2 Modulation in Human-Induced...

To whom correspondence should be addressed at Developmental Therapeutics Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute, NIH, 9609 Medical Center Drive, Room 4-W116, MSC 9734, Bethesda, MD 20892-9740. E-mail: Human-induced pluripotent stem cell-derived cardiomyocytes are being used as an in vitro model system in cardiac biology and in drug discovery .

http://ift.tt/1s1ZG3Y